This is a phoenix rebirth.
TIS is a dead bird, FTT is alive and much stronger than TIS.
We have a fantastic molecule, a fantastic long list of potential new products pipeline based on the outstanding technology, fantastic new management, strong believers, funds with vision, and a huge market ahead with a need for a new technology and application that will build a substantial competitive advantage and will help thousands of patients. This is ethic!
The current semester will position potentially FTT in the top performers.
Soon or later the market will wake up and then many small investors will regret to have stayed with the old TIS prejudice and philosophy. It is too easy to speak about past failures. Winners are a reflection of progress.
If the private investors are still hesitant, I can offer $ 1.000 in a bet.
If FTT will succeed in the VF001 trial I should be paid 100 times my bet, if I loose I will deliver my $1.000 to the winner.
Now, let's play. This is a game.
If anyone knows about crypt-currency and the availability to maintain privacy, a platform for such bet could be created.
- Forums
- ASX - By Stock
- Ann: Ocular Wound Care Program Update
This is a phoenix rebirth. TIS is a dead bird, FTT is alive and...
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online